Nitorum Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jack in the Box
JACK
|
+$5.78M |
| 2 |
Haemonetics
HAE
|
+$3.39M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$3.32M |
| 4 |
Aramark
ARMK
|
+$3.03M |
| 5 |
Greenlight Captial
GLRE
|
+$2.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$4.09M |
| 2 |
Fidelity National Information Services
FIS
|
+$2.11M |
| 3 |
KLXI
KLX Inc.
KLXI
|
+$1.98M |
| 4 |
Valmont Industries
VMI
|
+$1.46M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.05% |
| 2 | Financials | 22.88% |
| 3 | Consumer Staples | 15.66% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Healthcare | 9.36% |
Similar funds
Nitorum Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Nitorum Capital held 26 positions worth $210M, up 8.5% from $193M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Nitorum Capital deployed $10.6M of net new capital in Q2 2016, opening 3 new positions and adding to 12 existing holdings. Its largest new stake was Jack in the Box: 76,610 shares worth $6.58M.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Fidelity National Information Services, an estimated $2.11M trimmed.
- Nitorum Capital's largest Q2 2016 buy was Jack in the Box: 76,610 shares worth $6.58M.
- Nitorum Capital added most to Haemonetics in Q2 2016, an estimated $3.39M increase.
- Nitorum Capital's biggest Q2 2016 reduction was Fidelity National Information Services, cutting an estimated $2.11M.
- Nitorum Capital fully exited Mead Johnson Nutrition Company in Q2 2016, selling an estimated $4.09M.
- Nitorum Capital's ten largest holdings make up 60% of its $210M portfolio in Q2 2016.
- Nitorum Capital opened 3 new positions and closed 1 in Q2 2016.
- Nitorum Capital's portfolio value rose 8.5% quarter-over-quarter to $210M.
Based on Nitorum Capital's 13F filing for Q2 2016, filed 15 Aug 2016.